Gene-specific mutagenesis enables rapid continuous evolution of enzymes in vivo

Nucleic Acids Res. 2021 Apr 6;49(6):e32. doi: 10.1093/nar/gkaa1231.

Abstract

Various in vivo mutagenesis methods have been developed to facilitate fast and efficient continuous evolution of proteins in cells. However, they either modify the DNA region that does not match the target gene, or suffer from low mutation rates. Here, we report a mutator, eMutaT7 (enhanced MutaT7), with very fast in vivo mutation rate and high gene-specificity in Escherichia coli. eMutaT7, a cytidine deaminase fused to an orthogonal RNA polymerase, can introduce up to ∼4 mutations per 1 kb per day, rivalling the rate in typical in vitro mutagenesis for directed evolution of proteins, and promotes rapid continuous evolution of model proteins for antibiotic resistance and allosteric activation. eMutaT7 provides a very simple and tunable method for continuous directed evolution of proteins, and suggests that the fusion of new DNA-modifying enzymes to the orthogonal RNA polymerase is a promising strategy to explore the expanded sequence space without compromising gene specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytidine Deaminase / genetics
  • DNA-Directed RNA Polymerases / genetics
  • Directed Molecular Evolution / methods*
  • Escherichia coli / genetics
  • Heat-Shock Proteins / genetics
  • High-Throughput Nucleotide Sequencing
  • Mutagenesis*
  • Periplasmic Proteins / genetics
  • Proteins / genetics
  • Serine Endopeptidases / genetics

Substances

  • Heat-Shock Proteins
  • Periplasmic Proteins
  • Proteins
  • DNA-Directed RNA Polymerases
  • DegP protease
  • Serine Endopeptidases
  • Cytidine Deaminase